Novo Nordisk A/S
NVO
$58.20
$1.001.75%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.14% | -10.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.14% | -10.05% | |||
| Cost of Revenue | 7.47% | 5.48% | |||
| Gross Profit | 5.87% | -12.59% | |||
| SG&A Expenses | 26.15% | -21.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 277.15% | 98.13% | |||
| Total Operating Expenses | 19.12% | -10.02% | |||
| Operating Income | -7.02% | -10.07% | |||
| Income Before Tax | -1.57% | 2.80% | |||
| Income Tax Expenses | -1.56% | 7.76% | |||
| Earnings from Continuing Operations | -1.57% | 1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.57% | 1.52% | |||
| EBIT | -7.02% | -10.07% | |||
| EBITDA | -4.75% | -4.99% | |||
| EPS Basic | -1.65% | 1.66% | |||
| Normalized Basic EPS | -1.65% | -11.61% | |||
| EPS Diluted | -1.57% | 1.69% | |||
| Normalized Diluted EPS | -1.57% | -11.55% | |||
| Average Basic Shares Outstanding | 0.09% | -0.15% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||